Status:
COMPLETED
Zanzibar Stroke Study: Narrowing the Gaps in Hypertension Care, and Improving Stroke Outcomes (ZanStroke)
Lead Sponsor:
Jutta Mari Adelin Jorgensen
Collaborating Sponsors:
Newcastle University, UK
Vervig (IoM)
Conditions:
Stroke
Eligibility:
All Genders
18+ years
Brief Summary
Background: A previous study in Zanzibar (which Jutta Adelin Jorgensen, PI of ZanStroke, led) showed a high prevalence of hypertension among adults at 33%, in fact higher than average in Sub-Saharan ...
Detailed Description
Current and future benefits and impacts: With the demographic transition and population ageing in SSA rates of stroke are set to continue to increase rapidly as part of the double burden of disease (...
Eligibility Criteria
Inclusion
- admitted with a clinical diagnosis of stroke, or developing stroke while in hospital admitted for other cause (see below for stroke case definition)
- age above 18 year
- written consent form signed by patient, or authorized representative (spouse or caretaker)
- stroke onset \< 30 days when enrolled
Exclusion
- patient or authorized representative unable to understand the information given or being interviewed.
- CT scan not suspect of stroke despite clinical suspect
- Stroke case definition:
- All the following stroke categories listed below that have been submitted as the most responsible diagnosis will be included in the stroke cohort. For patients developing stroke while admitted to hospital, stroke as the second diagnosis will also be included in the cohort. Patients who previously had a stroke and are being admitted due to complications, and where stroke is not the primary diagnosis during admission, will not be included in the cohort.
- Definition of stroke ( ICD-10 classification code in parenthesis) that will be used in the study for inclusion in the cohort:
- (a) Intracerebral hemorrhage (I61 including all sub-codes) (b) Ischemic stroke (I63 including all sub-codes, H34.1) (c) Stroke, not specified as hemorrhagic or ischemic (I64) (d) Cerebral Venous Thrombosis, non-pyogenic (I63.6) Where CTscan is not available, the clinical diagnosis of stroke will be used, and coding will be I64 (ICD-10)
- \-
Key Trial Info
Start Date :
October 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 5 2022
Estimated Enrollment :
869 Patients enrolled
Trial Details
Trial ID
NCT04095806
Start Date
October 1 2019
End Date
May 5 2022
Last Update
May 6 2022
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Kivunge District Hospital
Kinyasini, Zanzibar, Tanzania
2
Mnazi Mmoja Hospital
Zanzibar, Tanzania, 236
3
Al Rahma Hospital
Zanzibar, Tanzania
4
Bububu Military Hospital
Zanzibar, Tanzania